Zhitong Finance App News, China Biotech Service (08037.HK) announced that on September 2, 2026, the company's subsidiary Pengbo (Hainan) Boron Neutron Medical Technology Co., Ltd. (operated under the commercial name “Pengbo (Hainan) Boron Neutron Hospital”) will establish a framework cooperation agreement for the Group's flagship boron neutron capture treatment project located in the Boao Lecheng International Medical Tourism Pilot Zone in Hainan Province, China, with Hong Kong Comprehensive Oncology Specialist Institution and Ankang Cancer Medical Center (Ankang), a member organization of Tianma Medical Group (Tianma Medical) medical services, Collaborate on two-way referrals and related services.

Zhitongcaijing · 4d ago
Zhitong Finance App News, China Biotech Service (08037.HK) announced that on September 2, 2026, the company's subsidiary Pengbo (Hainan) Boron Neutron Medical Technology Co., Ltd. (operated under the commercial name “Pengbo (Hainan) Boron Neutron Hospital”) will establish a framework cooperation agreement for the Group's flagship boron neutron capture treatment project located in the Boao Lecheng International Medical Tourism Pilot Zone in Hainan Province, China, with Hong Kong Comprehensive Oncology Specialist Institution and Ankang Cancer Medical Center (Ankang), a member organization of Tianma Medical Group (Tianma Medical) medical services, Collaborate on two-way referrals and related services.